Open Access

Assay of hemoglobin A1c using lectin from Aleuria aurantia

  • Masato Kabata1,
  • Erina Hase2,
  • Kouta Kimura2, 4,
  • Yuka Kobayashi3,
  • Yasushi Ueno3 and
  • Kazuaki Yoshimune1, 2Email author
AMB Express20166:119

DOI: 10.1186/s13568-016-0288-7

Received: 14 October 2016

Accepted: 8 November 2016

Published: 22 November 2016

Abstract

Hemoglobin A1c (HbA1c) has an N-terminal fructosyl valine on the β-chain, and this modification is caused by the non-enzymatic glycosylation of hemoglobin (Hb). The relative concentration ratio of HbA1c to total Hb is an important biomarker for the diagnosis of diabetes. HbA1c-binding lectins were screened from 29 sources of lectin, and the lectin from Aleuria aurantia (AAL) was revealed to have higher affinity to HbA1c than to Hb. The concentration of HbA1c was determined by lectin-based enzyme-linked immunosorbent assay (ELISA) using the AAL lectin. Higher reproducibility of the assay was observed at 4 °C than at 25 and 37 °C. This observation is consistent with the known temperature-dependent behavior of lectins. Preincubation of HbA1c with an anti-HbA1c antibody inhibited the binding, suggesting that AAL binds to the N-terminal fructosyl valine epitope of HbA1c. Higher inhibitory effect was observed for 10 mM d-fructose than for the same concentrations of l-fucose, d-fucose, or d-glucose.

Keywords

Lectin Aleuria aurantia Hemoglobin A1c Lectin-based enzyme-linked immunosorbent assay

Introduction

The number of people with diabetes is increasing globally, especially in developing countries, with over 346 million people diagnosed worldwide (Little and Rohlfing 2013). The major hallmark of diabetes is high glucose levels in the blood. However, the concentration of glucose in the blood is not reliable for the diagnosis of diabetes because of fluctuations in these concentrations throughout the day. The relative concentration ratio of hemoglobin A1c (HbA1c) to hemoglobin (Hb) is a reliable biomarker for the diagnosis and prognosis of diabetes (Little and Rohlfing 2013). HbA1c is produced by a non-enzymatic reaction between glucose (McDonald et al. 1978) and the N-terminal valine of the β-chain of hemoglobin in red blood cells. The reaction proceeds via a Schiff base adduct, followed by the Amadori rearrangement to form a stable fructosyl valine, which exists almost exclusively in the pyranose form (Mortensen and Christophersen 1982). Since the half-life of red blood cells is approximately 2 months, the concentration of HbA1c represents the blood glucose levels over the past 2–3 months. Since the first quantitative assay of HbA1c (Trivelli et al. 1971), the assay method has been improved by a rapid automated assay (Klenk et al. 1982) and an automated immunoassay (Fiore et al. 1988), and the enzymatic assay using fructosyl amino acid oxidase (Sakurabayashi et al. 2003). Conventional HbA1c assay methods available to clinical laboratories are based on the chromatographic method (Imagawa et al. 1984), the latex-enhanced immunoturbidimetric method (Holownia et al. 1997), or the enzymatic method using fructosyl-valine oxidase (Hirokawa et al. 2004). The chromatographic method, involving the use of HPLC for the separation of HbA1c and Hb, is rather expensive. The latex-enhanced immunoturbidimetric method monitors increase in solution turbidity, which is caused by the interactions between HbA1c and the antibodies against fructosyl-valine of HbA1c that are coated on the surface of latex beads. In this method, HbA1c is denatured before the assay so that the N-terminal fructosyl valine is exposed (Holownia et al. 1997). The enzymatic method uses fructosyl-valine oxidase for oxidation of the glycated N-terminal amino group of the partially digested HbA1c to produce hydrogen peroxide, which is subsequently used for color development.

Lectins are carbohydrate-binding proteins produced by many organisms including fungi, animals, plants, and bacteria. Binding affinity of some lectins to glycoprotein increases at lower temperatures (Hayes and Goldstein 1975; Ebisu et al. 1978; Damian et al. 2005). It is hypothesized that water molecules contribute to the binding between sugar and lectin, and tend to be displaced at higher temperatures (Damian et al. 2005). Fungal lectin from Aleuria aurantia (AAL) is a fucose binding lectin, and the binding is inhibited by l-fucose, but not by d-fucose. AAL differs from other fucose-binding lectins by having a broad affinity towards l-fucose-containing saccharides (Olausson et al. 2008). AAL can be used for the assay of serum fucosylated haptoglobin for diagnosis of hepatocellular carcinoma (Kondo et al. 1995). AAL also binds to d-arabinose, which lacks the C-6 methyl group of l-fucose (Fukumori et al. 1990), although the binding affinity to it is 30 times weaker than that to l-fucose (Fujihashi et al. 2003). Recombinant AAL can be overproduced in Escherichia coli (Fukumori et al. 1990), and the overproduced AAL is stable after incubation at 55 °C for 10 min (Amano et al. 2003). AAL is composed of two identical subunits of approximately 33 kDa, and each subunit has its sixfold β-propeller structure with five l-fucose-binding sites to bind to the α- or β-anomer form of l-fucose (Fujihashi et al. 2003; Wimmerova et al. 2003).

This study revealed an interaction between AAL and HbA1c using a lectin-based ELISA method. This finding can be applied to develop an HbA1c assay for the diagnosis of diabetes. AAL offers several advantages for use in an HbA1c assay, such as its thermostability and the lower cost of production than that of antibody- or enzyme-based assays, which are the currently used methods.

Materials and methods

Materials

All biotinylated lectins described in this report were obtained from J-oil Mills, Inc., Tokyo, Japan. ELISA plates (half area 96 well, flat bottom) were purchased from Greiner Bio-One, Frickenhausen, Germany. Human hemoglobin was obtained from Sigma-Aldrich (St. Louis, MO, USA). Highly purified HbA1c was purchased from BBI Solutions (Cardiff, UK). Monoclonal antibody against HbA1c was purchased from Abnova Corp. (Taipei, Taiwan). Bovine serum albumin for the blocking of the plates was purchased from Jackson Immuno Research Laboratories (West Grove, PA, USA). All the other reagents were purchased from Wako Pure Chemical Industries (Osaka, Japan), unless otherwise stated.

Lectin-based ELISA

Interactions between AAL and Hb or HbA1c were assayed by lectin-based ELISA. Hb or HbA1c was denatured by incubation in 1.0 M acetate buffer (pH 5.0) for 30 min at 25 °C. A volume of 25 μl of denatured Hb or HbA1c (150 μg/ml) was added to the ELISA plate, and each well was washed with PBS-T, consisting of PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4) and 0.05 % Tween 20, and then blocked by the addition of 1 mg/ml BSA in PBS at 37 °C for 60 min. After washing with PBS-T, the plate was incubated with 25 μl of biotinylated lectin (5 μg/ml) in PBS with 1 mg/ml BSA for 1 h. Biotin labeled-lectins from Aleuria aurantia (AAL), Agaricus bisporus (ABA), Amaranthus caudatus (ACA), Agrocybe cylindracea (ACG), Arachis hypogaea (PNA), Bauhinia purpurea (BPA), Canavalia ensiformis (ConA), Canavalia gladiata (CGA), Galanthus elwesii (GEA), Glycine max (SBA), Dolichos biflorus (DBA), Datura stramonium (DSA), Erythrina cristagalli (ECA), Galanthus elwesii (GEA), Hippeatrum hybrid (HHA), Hygrophorus russula (HRL), Lens culinaris (LCA), Lotus tetragonolobus (Lotus), Maackia amurensis (MAM), Maclura pomifera (MPA), Phaseolus vulgaris (PHA-E4 and PHA-L4), Pholiota squarrosa (PhoSL), Psophocarpus tetragonolobus (PTA-I), Ricinus communis (RCA120), Sambucus sieboldiana (SSA), Triticum vulgaris (WGA), Tulipa gesneriana (TxLc-I), Ulex europaeus (UEA-I), and Vicia villosa (VVA-G) were screened. After washing with PBS-T, 25 μl of high sensitivity streptavidin-HRP (1 μg/ml, Thermo Fisher Scientific, Waltham, MA, USA) in PBS with 1 mg/ml BSA was added and incubated for 1 h. After washing with PBS-T, color was developed with TMB peroxidase substrate system (KPL, Gaithersburg, MD, USA) according to the manufacturer’s instructions.

After the screening experiment, the subsequent experiments were further optimized. The denatured Hb or HbA1c was neutralized by the addition of more than ten times the initial volume of 0.1 M sodium carbonate buffer (pH 9.5) for the efficient binding to the ELISA plate. Furthermore, the plates were kept at 4 °C after the addition of biotinylated AAL for the reproducibility. The inhibitory effect of the anti-HbA1c antibody (10 μg/ml) was determined by adding it to the neutralized HbA1c after denaturation. For the assay of the inhibitory effect of sugars, biotinylated AAL was incubated with 10 mM l-fucose, d-fucose, d-fructose, or d-glucose before its addition to the plate. All data are shown as the mean value of at least three measurements with error bars of one standard deviation.

Results

Screening of HbA1c-binding lectins

HbA1c-binding lectins were screened from 30 sources using lectin-based ELISA, as described in the “Materials and methods” section. Among the screened lectins, eight (AAL, DBA, ECA, HHA, LCA, Lotus, MPA, and UEA-I) were found to bind to HbA1c, although they showed similar or higher binding-affinity to Hb except for AAL (Fig. 1). AAL was selected for further experiments as it was found to bind with HbA1c, but not with Hb. The binding Fig. 2 shows the binding between AAL and HbA1c and between AAL and Hb. The results show that AAL binding increased as the HbA1c concentration increased. However, only a small increase in binding was observed when the Hb concentration increased. The neutralization before the addition of the ELISA plates increased the values of ELISA, because high pH buffer can increase the solubility of the proteins and makes the proteins unprotonated which helps binding to a positively charged ELISA plates.
Fig. 1

Screening of hemoglobin A1c-binding lectins. The denatured hemoglobin A1c (white) or hemoglobin (black) was immobilized on the surface of the plate before the neutralization. The binding of biotinylated lectins was assayed by the activity of the specifically bound streptavidin-HRP

Fig. 2

Binding between the lectin from Aleuria aurantia (AAL) and HbA1c or Hb. The denatured HbA1c (filled circle) or Hb (open square) were immobilized on the surface of the plate and the amount of biotinylated AAL bound to the protein was assayed by the activity of the specifically bound streptavidin-HRP

Effect of temperature

Binding affinities between lectins and saccharides are often enhanced at lower temperatures. The effect of temperature on the lectin-based ELISA was determined by decreasing the solution temperature after the addition of biotinylated AAL as described in the “Materials and methods” section. Although the solution temperature has a slight effect on the average values of binding to HbA1c (data not shown), higher reproducibility was observed at lower temperatures. The average of coefficient of validation for the values of HbA1c binding, as shown in Fig. 2, was 0.049. However, this average value at 25 and 37 °C, increased to 0.080 and 0.11, respectively (data not shown).

Inhibitory effect of the anti-HbA1c antibody

The inhibitory effect of the monoclonal antibody against the N-terminal fructosyl valine of β-chain of HbA1c on the binding between AAL and HbA1c was assayed in order to obtain information about the binding position of HbA1c. The antibody was incubated with denatured HbA1c and lectin-based ELISA was performed. Figure 3 shows the effect of the antibody on the binding. The binding was inhibited by the incubation of the antibody and HbA1c prior to the lectin-based ELISA. This result suggests that AAL binds to the N-terminal fructosyl valine of the β-chain of HbA1c.
Fig. 3

Inhibition of the binding by the monoclonal antibody against HbA1c. The lectin-based ELISA was performed in the presence (open triangle) and the absence (closed circle) of the anti-HbA1c monoclonal antibody (10 μg/ml)

l-Fucose occupies the binding sites of AAL and inhibits the binding of AAL to l-fucose-containing glycans. The binding sites of AAL to HbA1c were assumed by determining the inhibition effects of various sugars. Table 1 shows the effect of 10 mM l-fucose, d-fucose, d-fructose, d-glucose, and d-arabinose on the interaction between AAL and HbA1c. The inhibition by d-fructose was higher than that by the other sugars, including l-fucose. These results suggest that AAL binds to the N-terminal fructosyl valine at a binding site distinct from that of l-fucose.
Table 1

Inhibitory effect of sugars on the values of the lectin-based ELISA

 

Valuesa

Inhibition (%)

None

0.81

0

l-Fucose

0.60

26

d-Fucose

0.70

14

d-Fructose

0.47

42

d-Glucose

0.68

16

d-Arabinose

0.67

17

aThe values of the lectin-based ELISA for 0.15 μg HbA1c in the presence and the absence of 10 mM sugars. The control values are reduced

Discussion

This report revealed that AAL binds to HbA1c, which is a glucose modified Hb. This is the first report showing interaction between HbA1c and AAL, which has been shown to interact with saccharides containing l-fucose or d-arabinose. The results of the lectin-based ELISA (Fig. 2) showed that AAL has more binding affinity with HbA1c than that with Hb. Since the modification by glucose differentiates HbA1c from Hb, AAL is suggested to bind to fructosyl valine of the β-chain of HbA1c. This hypothesis is consistent with the observed inhibitory effect of the antibody against fructosyl valine (Fig. 3). This binding is explained by the broad binding affinity of lectin. AAL also binds to d-arabinose, which lacks the C-6 methyl group of l-fucose, although the binding affinity is 30 times weaker than that to l-fucose (Fujihashi et al. 2003). Figure 4 compares the structural formulas of the hypothetical ligand d-fructosyl valine and its known ligands l-fucose and d-arabinose. Three of these pyranoses share the same configuration of all four hydroxyl groups at chiral carbons (C-1, C-2, C-3, and C-4). It is possible that AAL binds to the fructosyl valine of β-chain of HbA1c, as does l-fucose-containing saccharides. However, the binding may be partially distinct from each other, which could result in the distinct inhibition in the presence of l-fucose or l-fructose.
Fig. 4

Comparison of structural formulas of fructosyl valine and the known ligands of AAL

The reproducibility increased at 4 °C as compared to 25 and 37 °C. These results are likely caused by the higher binding affinity at lower temperatures. Higher affinity at lower temperature is often reported in the interactions between lectins and saccharides. Damian et al. (2005) suggested that the higher affinity at lower temperatures is caused by stabilization of water molecules that contribute to the binding. The interaction between AAL and HbA1c may require water molecules.

AAL could be used for the assay of HbA1c in human blood for the diagnosis of diabetes. Since AAL can be overproduced in E. coli and shows higher thermostability, a diagnostic test using AAL may be superior to the conventional assay using the antibody against HbA1c.

Abbreviations

HbA1c

hemoglobin A1c

Hb: 

hemoglobin

AAL: 

lectin from Aleuria aurantia

ELISA: 

enzyme-linked immunosorbent assay

DBA: 

lectin from Dolichos biflorus

ECA: 

lectin from Erythrina cristagalli

LCA: 

lectin from Lens culinaris

Lotus: 

lectin from Lotus tetragonolobus

HHA: 

lectin from Hippeatrum hybrid

MPA: 

lectin from Maclura pomifera

UEA-1: 

lectin from Ulex europaeus

Declarations

Authors’ contributions

Performed the experiments MK, EH, KK. Contributed materials: YK, YU. Designed the experiments and wrote the paper KY. All authors read and approved the final manuscript.

Acknowledgements

Not Applicable.

Competing interests

The authors declare that they have no competing interests.

Ethics approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

(1)
Department of Applied Molecular Chemistry, Graduate School of Industrial Technology, Nihon University
(2)
Department of Applied Molecular Chemistry, College of Industrial Technology, Nihon University
(3)
Product Development Laboratory, J-oil Mills Inc.
(4)
Nacalai tesque Inc.

References

  1. Amano K, Takase M, Ando A, Nagata Y (2003) Production of functional lectin in Pichia pastoris directed by cloned cDNA from Aleuria aurantia. Biosci Biotechnol Biochem 67(10):2277–2279View ArticlePubMedGoogle Scholar
  2. Damian L, Fournier D, Winterhalter M, Paquereau L (2005) Determination of thermodynamic parameters of Xerocomus chrysenteron lectin interactions with N-acetylgalactosamine and Thomsen–Friedenreich antigen by isothermal titration calorimetry. BMC Biochem 6:11. doi:10.1186/1471-2091-6-11 View ArticlePubMedPubMed CentralGoogle Scholar
  3. Ebisu S, Iyer PNS, Goldstein IJ (1978) Equilibrium dialysis and carborydrate-binding studies on the 2-acetamido-2-deoxy-glucopyranosyl-binding lectin from Bandeiraea simplicifolia seeds. Carbohydr Res 61:129–138. doi:10.1016/S0008-6215(00)84473-0 View ArticleGoogle Scholar
  4. Fiore M, Mitchell J, Doan T, Nelson R, Winter G, Grandone C, Zeng K, Haraden R, Smith J, Harris K et al (1988) The Abbott IMx automated benchtop immunochemistry analyzer system. Clin Chem 34(9):1726–1732PubMedGoogle Scholar
  5. Fujihashi M, Peapus DH, Kamiya N, Nagata Y, Miki K (2003) Crystal structure of fucose-specific lectin from Aleuria aurantia binding ligands at three of its five sugar recognition sites. Biochemistry 42(38):11093–11099View ArticlePubMedGoogle Scholar
  6. Fukumori F, Takeuchi N, Hagiwara T, Ohbayashi H, Endo T, Kochibe N, Nagata Y, Kobata A (1990) Primary structure of a fucose-specific lectin obtained from a mushroom, Aleuria aurantia. J Biochem 107(2):190–196PubMedGoogle Scholar
  7. Hayes CE, Goldstein IJ (1975) Equilibrium dialysis and cell binding studies on Bandeiraea simplicifolia lectin. J Biol Chem 250(17):6837–6840PubMedGoogle Scholar
  8. Hirokawa K, Nakamura K, Kajiyama N (2004) Enzymes used for determination of HbA1c. FEMS Microbiol Lett 235:157–162. doi:10.1111/j.1574-6968.2004.tb09581 View ArticlePubMedGoogle Scholar
  9. Holownia P, Bishop E, Newman DJ, John WG, Price CP (1997) Adaptation of latex-enhanced assay for percent glycohemoglobin to a Dade Dimension analyzer. Clin Chem 43(1):76–84PubMedGoogle Scholar
  10. Imagawa S, Abe T, Kimura S, Sugita Y, Yamashita K (1984) Studies on subfractions of hemoglobin A1b and hemoglobin A1c in diabetic subjects. Endocrinol Jpn 31(6):725–731. doi:10.1507/endocrj1954.31.725 View ArticlePubMedGoogle Scholar
  11. Klenk DC, Hermanson GT, Krohn RI, Fujimoto EK, Mallia AK, Smith PK, England JD, Wiedmeyer HM, Little RR, Goldstein DE (1982) Determination of glycosylated hemoglobin by affinity chromatography: comparison with colorimetric and ion-exchange methods, and effects of common interferences. Clin Chem 28(10):2088–2094PubMedGoogle Scholar
  12. Kondo M, Hada T, Fukui K, Iwasaki A, Higashino K, Yasukawa K (1995) Enzyme-linked immunosorbent assay (ELISA) for Aleuria aurantia lectin-reactive serum cholinesterase to differentiate liver cirrhosis and chronic hepatitis. Clin Chim Acta 243(1):1–9View ArticlePubMedGoogle Scholar
  13. Little RR, Rohlfing CL (2013) The long and winding road to optimal HbA1c measurement. Clin Chim Acta 418:63–71. doi:10.1016/j.cca.2012.12.026 View ArticlePubMedPubMed CentralGoogle Scholar
  14. McDonald MJ, Shapiro R, Bleichman M, Solway J, Bunn HF (1978) Glycosylated minor components of human adult hemoglobin. Purification, identification, and partial structural analysis. J Biol Chem 253(7):2327–2332PubMedGoogle Scholar
  15. Mortensen HB, Christophersen C (1982) Glycosylation of human hemoglobin A. Kinetics and mechanisms studied by isoelectric focusing. Biochim Biophys Acta 707(1):154–163. doi:10.1016/0167-4838(82)90409-5 View ArticlePubMedGoogle Scholar
  16. Olausson J, Tibell L, Jonsson BH, Pahlsson P (2008) Detection of a high affinity binding site in recombinant Aleuria aurantia lectin. Glycoconj J 25(8):753–762. doi:10.1007/s10719-008-9135-7 View ArticlePubMedGoogle Scholar
  17. Sakurabayashi I, Watano T, Yonehara S, Ishimaru K, Hirai K, Komori T, Yagi M (2003) New enzymatic assay for glycohemoglobin. Clin Chem 49(2):269–274View ArticlePubMedGoogle Scholar
  18. Trivelli LA, Ranney HM, Lai HT (1971) Hemoglobin components in patients with diabetes mellitus. N Engl J Med 284(7):353–357View ArticlePubMedGoogle Scholar
  19. Wimmerova M, Mitchell E, Sanchez JF, Gautier C, Imberty A (2003) Crystal structure of fungal lectin: six-bladed beta-propeller fold and novel fucose recognition mode for Aleuria aurantia lectin. J Biol Chem 278(29):27059–27067View ArticlePubMedGoogle Scholar

Copyright

© The Author(s) 2016